EUR 0.4
(2.18%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.88 EUR | 29.03% |
2022 | -1.24 EUR | 25.3% |
2021 | -1.66 EUR | -40.68% |
2020 | -1.18 EUR | 23.87% |
2019 | -1.55 EUR | 8.82% |
2018 | -1.70 EUR | -150.0% |
2017 | -0.68 EUR | 62.01% |
2016 | -1.79 EUR | -208.62% |
2015 | -0.58 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 0.01 EUR | 0.0% |
2023 Q4 | -0.41 EUR | 0.0% |
2023 FY | - EUR | 28.23% |
2023 Q2 | -0.69 EUR | 0.0% |
2022 Q4 | -0.62 EUR | 0.0% |
2022 FY | - EUR | 25.3% |
2022 Q2 | -0.62 EUR | 0.0% |
2021 Q2 | -0.81 EUR | 0.0% |
2021 FY | - EUR | -40.68% |
2021 Q4 | -0.81 EUR | 0.0% |
2020 Q4 | -0.47 EUR | 0.0% |
2020 FY | - EUR | 23.87% |
2020 Q2 | -0.80 EUR | 0.0% |
2019 FY | - EUR | 8.82% |
2019 Q4 | -0.78 EUR | 0.0% |
2019 Q2 | -0.90 EUR | 0.0% |
2018 FY | - EUR | -150.0% |
2018 Q4 | -1.04 EUR | 0.0% |
2018 Q2 | -0.66 EUR | 0.0% |
2017 FY | - EUR | 62.01% |
2017 Q4 | -0.26 EUR | 0.0% |
2017 Q1 | -0.17 EUR | 41.38% |
2017 Q2 | -0.80 EUR | -370.59% |
2016 Q2 | -0.41 EUR | -78.26% |
2016 FY | - EUR | -208.62% |
2016 Q1 | -0.23 EUR | 0.0% |
2016 Q4 | -0.29 EUR | 0.0% |
2015 Q2 | -0.08 EUR | 0.0% |
2015 Q3 | -0.08 EUR | 0.0% |
2015 Q4 | -0.23 EUR | -199.09% |
2015 FY | - EUR | 0.0% |
2015 Q1 | -0.08 EUR | 0.0% |
2014 Q4 | -0.08 EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
ABIONYX Pharma SA | -0.12 EUR | -633.333% |
ABIVAX Société Anonyme | -3.43 EUR | 74.344% |
Adocia SA | -1.91 EUR | 53.927% |
Aelis Farma SA | -0.39 EUR | -125.641% |
Biophytis S.A. | -12.55 EUR | 92.988% |
Advicenne S.A. | -0.67 EUR | -31.343% |
genOway Société anonyme | 0.17 EUR | 617.647% |
IntegraGen SA | -0.03 EUR | -3297.683% |
Medesis Pharma S.A. | -0.80 EUR | -10.0% |
Neovacs S.A. | -0.00 EUR | -35100.0% |
NFL Biosciences SA | -0.46 EUR | -91.304% |
Plant Advanced Technologies SA | 0.07 EUR | 1357.143% |
Quantum Genomics Société Anonyme | -0.09 EUR | -867.033% |
Sensorion SA | -0.17 EUR | -417.647% |
TME Pharma N.V. | -1.34 EUR | 34.328% |
Valbiotis SA | -0.59 EUR | -49.153% |
TheraVet SA | -0.49 EUR | -79.592% |
Valerio Therapeutics Société anonyme | -0.15 EUR | -486.667% |
DBV Technologies S.A. | -0.71 EUR | -23.944% |
Genfit S.A. | -0.58 EUR | -51.724% |
GeNeuro SA | -0.59 EUR | -49.153% |
Innate Pharma S.A. | -0.09 EUR | -835.175% |
Inventiva S.A. | -2.43 EUR | 63.786% |
MaaT Pharma SA | -1.73 EUR | 49.133% |
MedinCell S.A. | -0.88 EUR | -0.0% |
Nanobiotix S.A. | -1.08 EUR | 18.519% |
OSE Immunotherapeutics SA | -1.18 EUR | 25.424% |
Poxel S.A. | -0.91 EUR | 3.297% |
GenSight Biologics S.A. | -0.54 EUR | -62.963% |
Transgene SA | -0.22 EUR | -300.0% |
Valneva SE | -0.73 EUR | -20.548% |